InstalabLoading...
InstalabLoading...
If you have ever dealt with stubborn diarrhea that no one could explain, or if you live with a condition that weakens your immune system, this test answers a question most stool workups skip: are tiny spore-forming parasites called microsporidia living in your gut? These organisms are common in animals and water, can be picked up without you noticing, and most standard stool panels do not look for them at all.
Healthy immune systems often keep microsporidia in check, sometimes silently for years. But when defenses drop, the same organisms can cause persistent diarrhea, weight loss, or spread beyond the gut. Knowing whether you carry them puts a name to symptoms that otherwise get labeled as functional, and it shapes what your next step should be.
Microsporidia are a large group of spore-forming parasites that live inside the cells of their hosts. More than 200 genera and over 1,400 species have been described, with at least 17 species known to infect humans. One species, Enterocytozoon bieneusi (often shortened to E. bieneusi in research), accounts for over 90 percent of human cases. Several species in the Encephalitozoon group, including E. cuniculi and E. intestinalis, make up most of the rest.
These organisms live in the gut and can also reach the eyes, sinuses, lungs, kidneys, and other tissues. They spread through spores shed in stool and urine that contaminate water, food, and surfaces. Animals are major reservoirs: pigs, cattle, sheep, rabbits, and other mammals carry the same genotypes that infect people. In a global meta-analysis, microsporidia were found in 92 countries, with prevalence around 10.2 percent in humans, 39.3 percent in pigs, 16.6 percent in cattle, 24.9 percent in sheep, and 58.5 percent in water samples.
Microsporidia behave very differently depending on the strength of your immune system. The strongest evidence comes from people living with HIV (the virus that causes AIDS), organ transplant recipients, and others on medications that suppress immunity. In a study of 588 HIV-positive people in Guangxi, China, 11.58 percent tested positive, with higher rates in those living in rural areas and drinking unboiled water. In a study of 193 HIV-positive patients in Lagos, Nigeria, 23.3 percent had microsporidial spores in stool. In a French prospective study of 456 people, kidney transplant recipients had the highest prevalence among groups tested.
Healthy people are not exempt. A long-term study tracking immunocompetent adults found that latent microsporidial infections are common, often without any symptoms. Among 247 schoolchildren in Zambia and 436 children, adolescents, and young women in southern Madagascar, infection was widespread and largely silent. The concern is not always today's symptoms; it is what these organisms can do later if your immunity drops, for example during chemotherapy, transplant medications, or advanced HIV.
Microsporidiosis ranges from completely silent carriage to life-threatening illness. The most common picture is chronic, watery diarrhea, often lasting weeks to months, sometimes with weight loss and abdominal pain. In people with weakened immune systems, the parasite can spread beyond the gut and cause kidney, lung, eye, or brain involvement. Severe disease is most clearly tied to low CD4 counts (a measure of how strong the immune system is in HIV) and to the absence of antiretroviral therapy.
In otherwise healthy adults and children, infection is often asymptomatic and may resolve on its own. The clinical importance of a positive test depends heavily on context: your symptoms, your immune status, and whether other gut pathogens are present. A positive result in a healthy person without symptoms means something different than the same result in someone with active diarrhea or recent transplant medications.
Many of the genotypes that infect humans also infect animals, particularly E. bieneusi Group 1 strains. Genotype D is globally common and shared between people, livestock, and pets. In a study of 540 stool samples from diarrheal patients and animals in Yichun, China, several genotypes appeared in both, supporting transmission across species. If you live or work around farm animals, handle pets that drink from outdoor sources, or use well or untreated water, your exposure risk is meaningfully higher than for someone on chlorinated municipal water with limited animal contact.
This is a qualitative test. The lab reports whether microsporidial spores or DNA are detected in your stool, not a numeric concentration. Detection methods vary across labs and include PCR (a technique that amplifies parasite DNA), specialized stains viewed under a microscope, and immunofluorescence. Sensitivity differs by method, which matters when comparing results across labs or over time. Standardized clinical cutpoints for a quantitative microsporidial load do not exist.
Because there is no universal numeric scale, the framework below describes how to read a qualitative result. Different labs may use slightly different language.
| Result | What It Suggests | What to Consider |
|---|---|---|
| Not Detected | No microsporidial spores or DNA found in this sample | A negative result does not fully rule out infection if symptoms persist; intermittent shedding is well documented |
| Detected | Microsporidial spores or DNA present | Interpret alongside symptoms, immune status, and other gut pathogens; species-level identification is informative when available |
Interpretation depends on context. Compare your results within the same lab over time and pair them with symptom tracking, since detection method differences can shift apparent rates between labs.
Microsporidia are not shed evenly. A single negative stool can miss an active infection if spores were not present in that particular sample, and a single positive can reflect transient passage rather than established infection. If your symptoms are persistent, repeat testing on a different day, or testing across multiple stool samples, increases the chance of catching an infection that intermittent shedding would otherwise hide.
Trending also matters after treatment or after a change in immune status. If you have been treated for microsporidiosis, retesting confirms whether shedding has actually stopped. If your immune system is changing, for example starting or stopping immunosuppressive drugs, periodic testing can catch reactivation before it becomes symptomatic. A reasonable cadence is: a baseline test if you have risk factors or unexplained diarrhea, retest in 4 to 8 weeks if symptoms persist or after treatment, and at least annually for higher-risk situations.
A positive result is not a verdict, it is a starting point for a conversation. The next steps depend on three things: whether you have symptoms, your immune status, and which microsporidial species or genotype was found. If you have ongoing diarrhea, the result helps explain it and direct treatment. If you are immunocompromised, the result warrants prompt evaluation by an infectious disease or transplant specialist, since species like E. bieneusi and Encephalitozoon respond to different therapies and carry different risks.
If you are healthy and asymptomatic, a positive result usually reflects exposure rather than disease. The decision pathway in that case is to identify and reduce ongoing exposure (water source, animal contact, food handling), repeat testing in a few weeks, and pair the result with companion stool tests for other parasites and for inflammation. Useful complementary tests include cryptosporidium and giardia (parasites that share routes of exposure), calprotectin (a stool marker of gut inflammation), and a CD4 count if your immune status is uncertain.
Evidence-backed interventions that affect your Microsporidium Species level
Microsporidium Species is best interpreted alongside these tests.